Aptamers Market Growth, Market Insights and Forecast to 2025Posted by rekha on October 21st, 2019 The global aptamers market accounted for US$ 110 Mn in 2018 and burgeoning over the forthcoming years. Growing investment in research and development, increasing usage of aptamers in drug delivery and diagnostics, low-cost and high-efficiency as compared to antibodies and technological advancements for aptamers are some of the key factors favoring the market growth. However, factors such as lack of trained professionals and low market acceptance are the major factors hindering the market growth. Global aptamers market segmented on the basis of aptamers type, application, end user and region. Request for Sample Report @ https://www.precisionbusinessinsights.com/request-sample?product_id=16635 Nucleic acid aptamers dominate the Global Aptamers Market Based on aptamers type, global aptamers market is segmented intoNucleic acid aptamers, RNA-based, XNA-based, DNA-based and Peptide aptamers. Nucleic acid aptamers held considerable market growth during estimated period. Nucleic acid aptamers are a class of high affinity nucleic acid ligands. They work as “chemical antibodies” due to their high affinity and specificity. Nucleic acid aptamers are produced from nucleic acid random-sequence using a systematic evolution of ligands by exponential enrichment (SELEX) technology. North America Leads the Global Aptamers market PBI’s global aptamers market report analyses the market in different regions such as North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. According to regional analysis.North America accounted for larger revenue share in global aptamers market with considerable CAGR. The growth in this region can be attributed to rising funding & investment to the development of aptamers and technological advancements. Also, Asia Pacific held significant market share during estimated period owing to increasing R&D activities and positive government regulations in emerging countries like India and China.
Strategic Expansion are the Key Strategies Adopted by Market Players Global aptamers market further reveals that the key players increasingly adopting strategies such as launch of newer products, frequent product approvals, and long term alliance to improve market revenue share and gaining significant geographic presence across the region. For Instance, In May 2017, AptaTargets raised € 2.7 Mn funding from Caixa Capital Risc for the development of clinical trials for ApTOLL, a drug used in the treatment of acute ischemic stroke. Key player’s profiles in the report are NeoVentures Biotechnology, Inc. (Canada), Aptagen, LLC (U.S.), Aptamer Solutions Ltd. (U.K.), SomaLogic, Inc. (U.S.), AM Biotechnologies, LLC (U.S.), TriLink BioTechnologies, Inc. (U.S.), Vivonics, Inc. (U.S.), and Apta Targets (Spain). Precision Business Insights (PBI) in its report titled “Global Aptamers Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2014-2018 and Forecast 2019-2025” assesses the market performance over seven years forecast period over 2019-2025. The report analyses the market value forecast and provides the strategic insights into the market driving factors, challenges that are hindering the market revenue growth over forecast period. Moreover, the report also includes the total revenue and volume for the market. Detailed Segmentation
By Aptamers Type o Nucleic acid aptamers o RNA-based o XNA-based o DNA-based o Peptide aptamers By Application o Research & Development o Therapeutic development o Diagnostics By End User o Pharmaceutical companies o Biopharmaceutical companies o Research and academic institutes o Others
By Geography o North America
o Europe
o Asia-Pacific
o Latin America
o Middle East and Africa (MEA)
For more information: https://www.precisionbusinessinsights.com/market-reports/global-aptamers-market/
Like it? Share it! More by this author |